Claim Window Now CLOSED

CVS Class Action Lawsuit

Updated
CVS eye drops settlement: $1 million resolved claims over store-brand eye drops recalled after FDA investigators found unsanitary conditions at the maker's plant. CVS denies wrongdoing.
See settlements you can still claim

Chimo is a private monitoring and filing service and is not the court, the settlement administrator or a law firm.

Eye drop about to fall into an open eye – CVS eye drops class action

What happens next with the CVS settlement

The claim deadline passed on September 18, 2025. New claims for this settlement are no longer being accepted.

The court approved the settlement on November 18, 2025. Payments are sent once that approval is final: after the time for anyone to appeal it runs out, or after any appeal ends.

Then the payments go out. The settlement administrator, the firm the court appointed to process claims, sends payments to eligible claimants once it has reviewed the claims. How long that takes varies from one settlement to the next.

Filed this claim with Chimo? The status of your claim is on the claims page in your account.

CVS Class Action Lawsuit

Deborah Ruffin sued CVS Pharmacy, Inc. in federal court in North Carolina in 2023, after CVS-branded eye drops were recalled when FDA investigators found unsanitary conditions at the manufacturing facility in India. CVS denies that the products were defective and denies doing anything wrong, and the court has not decided who is right.

The CVS Eye Drops class action case alleges that CVS sold over-the-counter eye drops produced at that facility, which supplied CVS and other major retailers, until the FDA recommended a recall of all lots on October 25, 2023.

The lawsuit brought claims for breach of warranty, breach of contract, unjust enrichment and other state-law claims, filed by plaintiff Deborah Ruffin, who is represented by the law firm Poulin | Willey | Anastopoulo, LLC. The case, Ruffin v. CVS Pharmacy, Inc., Case No. 7:23-CV-01660-BO-RN (E.D.N.C.), covers purchases made between October 1, 2021, and October 25, 2023.

People who purchased the covered eye drops during this period were eligible to claim under the settlement, which the court approved after a hearing on October 28, 2025.

Lawsuit Name
Ruffin v. CVS Pharmacy Inc.
Court
United States District Court for the Eastern District of North Carolina, Southern Division
Case Number
7:23-CV-01660-BO-RN
Judge
Honorable Judge Terrence W. Boyle
Plaintiffs
Deborah Ruffin
Defendants
CVS Pharmacy, Inc.
Key Allegation
The lawsuit claims CVS sold store-brand eye drops made at an unsanitary facility in India, putting consumers at risk of eye infections.

CVS Class Action Settlement - $1,000,000

CVS Pharmacy, Inc. agreed to make up to $1,000,000 available to resolve legal claims after certain store-brand eye drops were recalled when FDA investigators found unsanitary conditions at the manufacturing facility in India. The settlement covers eligible consumers who purchased affected CVS-branded eye drop products in the United States between October 1, 2021, and October 25, 2023.

As part of the agreement, CVS also committed not to knowingly buy products from the manufacturer, Kilitch Healthcare India Ltd., under its current ownership through December 31, 2034. Eligible class members could claim cash awards, with or without proof of purchase. The claim deadline was September 18, 2025, and the court granted final approval after a hearing on October 28, 2025. Money left over, including uncashed checks, goes to the Wounded Warrior Project.

Claims closed: September 18, 2025

Eye Drops Class Action Payout: Share of up to $1 million fund

What an eligible claim was worth depended on proof of purchase and the number of valid claims. With proof of purchase, the settlement offered the amount actually paid for each product, multiplied by a time-discount rate. Without proof, eligible claimants could claim for up to three purchases and share pro rata in what remained of the fund, adjusted for each product's approximate retail price and the time-discount rate. The settlement documents give no fixed dollar figure per product.

Three things affect the payout:
Whether a claim included proof of purchase changes how it is calculated.
The number of valid claims affects each payment; the administrator received 34,745 claims that showed no substantial evidence of fraud.
The $1,000,000 fund also pays the fees, up to $300,000 requested by class counsel, a service award of up to $5,000 and administration costs, and awards shrink proportionally if claims exceed what remains.

Timeline:
The claim deadline was September 18, 2025.
The court held the fairness hearing on October 28, 2025, and granted final approval.
Under the settlement, valid claims are paid within 60 days of the effective date.

Delays may occur due to appeals or claim review. Questions about a claim go to the settlement administrator.

Eye Drops Class Action Eligibility

To determine CVS Eye Drops class action eligibility, the settlement defines the class as anyone in the U.S. who purchased covered CVS-branded eye drops between October 1, 2021, and October 25, 2023. The covered products are listed by their National Drug Codes in the settlement. The claim form asked four questions.

It asked which CVS eye drops products you purchased.

It asked for the dates and locations of purchase.

It asked whether you had proof of purchase (e.g., a receipt or CVS ExtraCare records).

It asked for contact details for payment delivery.

Claimants without proof of purchase had to swear under penalty of perjury to the products they bought and the date of each purchase, and could claim for no more than three purchases.

You purchased specified CVS-branded eye drops.
You made purchases between October 1, 2021, and October 25, 2023.

FAQ

Yes. Claimants didn’t need to have the product on hand. Claims were based on purchase history, not whether they still had the bottle.

If a claimant provided their ExtraCare number or phone number, the administrator would match it against CVS’s loyalty program data for the claim period.

Claimants could claim each type of product separately. A claim with proof is calculated from the amount actually paid; a claim without proof is calculated using the approximate retail price for each pack size, for up to three purchases in all.

No. Attorneys' fees (class counsel asked for up to $300,000), administration costs and the plaintiff's service award of up to $5,000 are all paid out of the $1 million settlement fund, which may reduce each eligible claimant's cash award.

As part of the settlement, CVS agreed it will not knowingly purchase products from Kilitch Healthcare India Ltd. under its current ownership through December 31, 2034. The settlement documents do not say whether CVS had stopped buying from Kilitch before that.

Sources

These are the court's own records for this case. They are hosted here unchanged, so you can check anything on this page against the documents themselves.

The full case file is on the court docket: view the docket.

CHIMO
Sign up for updates on new lawsuits
and unclaimed money opportunities
© 2026 Chimo AI Inc. - All rights reserved.

Chimo AI Inc. is a private company. We are not a law firm, do not give legal advice, and are not affiliated with or endorsed by any court, settlement administrator, defendant or government agency.

About Us Contact Us Privacy Policy Terms and Conditions